SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
A patient's ability to comply with sleep therapy, however, is affected by potential negative side effects, such as noise from the device, nasal dryness/congestion and breathing discomfort. To combat ...
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...
As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
SAN DIEGO, April 11, 2011 /PRNewswire/ -- ResMed Corp. (NYSE: RMD) today released its new S9 VPAP™ series of bilevel devices. Based on ResMed's latest design and technology platform, the new bilevels ...
The S9 Elite is a therapy system from Resmed that provides Continuous Positive Airway Pressure (CPAP). Sleep-Disordered Breathing (SDB) affects approximately one in every five adults in the UK. One of ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre ...
The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results